Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |